Your browser doesn't support javascript.
loading
Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2).
Lange, Lara M; Avenali, Micol; Ellis, Melina; Illarionova, Anastasia; Keller Sarmiento, Ignacio J; Tan, Ai-Huey; Madoev, Harutyun; Galandra, Caterina; Junker, Johanna; Roopnarain, Karisha; Solle, Justin; Wegel, Claire; Fang, Zih-Hua; Heutink, Peter; Kumar, Kishore R; Lim, Shen-Yang; Valente, Enza Maria; Nalls, Mike; Blauwendraat, Cornelis; Singleton, Andrew; Mencacci, Niccolo; Lohmann, Katja; Klein, Christine.
Afiliación
  • Lange LM; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Avenali M; IRCCS Mondino Foundation, Pavia, Italy.
  • Ellis M; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Illarionova A; Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, NSW, Australia.
  • Keller Sarmiento IJ; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Tan AH; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Madoev H; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Galandra C; Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Junker J; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Roopnarain K; IRCCS Mondino Foundation, Pavia, Italy.
  • Solle J; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Wegel C; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Fang ZH; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Heutink P; Department of Clinical Research, Michael J. Fox Foundation for Parkinson's Research, New York City, NY, USA.
  • Kumar KR; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Lim SY; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Valente EM; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Nalls M; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Blauwendraat C; Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, The University of Sydney, Concord, NSW, Australia.
  • Singleton A; Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Mencacci N; IRCCS Mondino Foundation, Pavia, Italy.
  • Lohmann K; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Klein C; Data Tecnica International, Washington, DC, USA.
NPJ Parkinsons Dis ; 9(1): 100, 2023 Jun 27.
Article en En | MEDLINE | ID: mdl-37369645
The Monogenic Network of the Global Parkinson's Genetics Program (GP2) aims to create an efficient infrastructure to accelerate the identification of novel genetic causes of Parkinson's disease (PD) and to improve our understanding of already identified genetic causes, such as reduced penetrance and variable clinical expressivity of known disease-causing variants. We aim to perform short- and long-read whole-genome sequencing for up to 10,000 patients with parkinsonism. Important features of this project are global involvement and focusing on historically underrepresented populations.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Parkinsons Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Parkinsons Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania
...